BARNES ALANE P (Senior VP, Chief Legal Officer) sold 27.2% of their position (150K shares) of BIOCRYST PHARMACEUTICALS INC on the open market
Open‑market sale worth $1.37M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/18/2026ACC: 0000882796-26-000015
Officer· Senior VP, Chief Legal Officer
Since Nov 2018
-150K
Net shares
Net seller
$1.37M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
150K acquired · 300K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+150K
Price / share
$5.51
Trade value
$826.50K
% of position
37.4%
3/16/2026
400.70K→550.70K
Common Stock
Direct
Shares
−150K
Price / share
$9.15
Trade value
$1.37M
% of position
27.2%
3/16/2026
550.70K→400.70K
Total
Net shares
+0.00
Net value
-$546K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/16/2026 | M · Option Exercise | +150K | $5.51 | $826.50K | 37.4% | 400.70K | 550.70K |
| Common Stock Direct | 3/16/2026 | S · Sale | −150K | $9.15 | $1.37M | 27.2% | 550.70K | 400.70K |
| Total | +0.00 | -$546K | ||||||
Derivative Transactions1
Emp. Stock Option (Right to Buy)
Direct
Converts to
Common Stock
150K shares
Shares
−150K
Strike price
5.51
Held after
0.00
Exercisable
—
3/16/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Emp. Stock Option (Right to Buy) Direct | Common Stock150K shares | 3/16/2026 | M · Option Exercise | −150K | 5.51 | — | 0.00 |